MolNFT v1 · #67125 · protein
Crystal structure of full length RV0805
3IB7 · Icc protein: “Crystal structure of full length RV0805”. X-ray diffraction, 2 ligands (FE, MN), 2 pockets (best druggability 0.49). MolNFT v1 #67125 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3IB7
- Type
- protein
- Length
- 295 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Icc protein
- EC
- 3.1.4.17
- UniProt
- O06629
- Ligands
- FE, MN
- Pockets
- 2 · best druggability 0.49
Structure
x-ray diffraction · 1 distinct chain · 26% helix, 24% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Icc protein (EC 3.1.4.17) | protein | 295 | 26% helix, 24% strand | O06629 |
Ligands and binding sites
- FE · Fe (III) ion · metal · chains A
- MN · Manganese (II) ion · metal · chains A
- ACT · Acetate ion · additive · 2 copies · chains A
- MPD · (4S)-2-methyl-2,4-pentanediol · additive · 2 copies · chains A
- BTB · 2-[bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 129 | 0.49 | 0.79 | 19 | ACT |
| 2 | 83 | 0.38 | 0.77 | 17 | MPD |
Compared structures
- 3IB7 · Crystal structure of full length Rv0805 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O06629
- Elsewhere: RCSB PDB 3IB7 · PDBe 3IB7 · UniProt O06629
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.